During the past decade, Connecticut Gastroenterology Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connecticut Gastroenterology Institute" #1 sponsor was "Bausch Health Americas, Inc." with 5 trials, followed by "Celgene" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Gastroenterology Institute" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Gastroenterology Institute" are "Ulcerative Colitis" (4 trials), "Crohn Disease" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Bowel Preparation" (1 trials) and "Clostridium Infections" (1 trials). Many other conditions were trialed in "Connecticut Gastroenterology Institute" in a lesser frequency.

Most popular intervention types in "Connecticut Gastroenterology Institute" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GED-0301" (2 trials), "5 ASA, enemas, suppositories, corticosteroids" (1 trials), "Asacol" (1 trials) and "Balsalazide Disodium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Gastroenterology Institute" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Connecticut Gastroenterology Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Connecticut Gastroenterology Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Gastroenterology Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".